Latest news
SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - The Malone TelegramThe Malone Telegram · Sat, 08 Aug 2026 18:36:00 GMTSPRY Deadline Alert: The Gross Law Firm Reminds ARS - GlobeNewswireGlobeNewswire · Fri, 07 Aug 2026 14:21:00 GMTSPRY Investor Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against ARS Pharmaceuticals Inc. - PR NewswirePR Newswire · Fri, 07 Aug 2026 11:21:00 GMTSPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit - PR NewswirePR Newswire · Fri, 07 Aug 2026 00:13:00 GMTSueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in ARS Pharmaceuticals Inc. Lawsuit - SPRY - PR NewswirePR Newswire · Thu, 06 Aug 2026 22:45:00 GMTRosen Law Firm Urges ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - Business WireBusiness Wire · Thu, 06 Aug 2026 21:49:00 GMTSPRY DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds ARS - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 16:13:31 GMTSPRY INVESTOR ALERT: Class Action Lawsuit Filed on Behalf - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 16:06:28 GMT